U.S. FDA Approves KERENDIA® (finerenone) to Treat Patients With Heart Failure With Left Ventricular Ejection Fraction ≥40% Following Priority Review
KERENDIA® (finerenone), a non-steroidal mineralocorticoid receptor antagonist (MRA), is the only MRA approved by the U.S. Food and Drug Administration (FDA) for... Read more.
Samsung Bioepis’ European Whitepaper Proposes Solutions to Bridge Policy Gaps that Hinder Healthy Market Competition and Timely Access to Biosimilar Medicines
Despite contributing €56 billion in cost savings across Europe, biosimilars face inadequate and misaligned policies that discourage continued investment in biosimilar... Read more.
Electronics Manufacturing Service Companies Scanfil and MB Elettronica to Join Forces
SIEVI, Finland–(BUSINESS WIRE)–#CircuitBoard–Finnish Scanfil, the largest European stock exchange listed Electronic Manufacturing Service company... Read more.
YT Jia Shares Weekly Investor Update: Actor Cody Walker to Speak Onsite and Reveal FX Product & Tech at the Global Initial Launch of the FX Super One MPV July 17
Four days away from the July 17th Global Initial Launch of the FX Super One & Super EAI F.A.C.E. & FF EAI Embodied AI Agent 6 x 4 Architecture. Cody Walker... Read more.
Owl Labs Launches in India with Award-Winning 360° Video Conferencing Technology
BANGALORE, India–(BUSINESS WIRE)–Owl Labs, a global leader in 360-degree video conferencing solutions and hybrid collaboration technology, has officially... Read more.
Golden Age Health and Innostellar Biotherapeutics Sign Exclusive 10-Year Collaboration to Accelerate LX-101 Gene Therapy for Inherited Retinal Dystrophies due to RPE 65 gene mutation in Mainland China
SHANGHAI–(BUSINESS WIRE)–Golden Age Health Pte. Ltd. (“GAH”) and Innostellar Biotherapeutics Co., Ltd. (“Innostellar”) today announced an exclusive... Read more.
Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025
– Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA Breakthrough Therapy designation, underway in... Read more.
PAL Investors Have Opportunity to Join Proficient Auto Logistics, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$PAL—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims... Read more.
LASE Investors Have Opportunity to Join Laser Photonics Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$LASE—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims... Read more.
JoAcademy Partners With Truecaller to Deliver Trusted, Contextual Communication Experience for the Student Ecosystem in Jordan
JoAcademy is enhancing student engagement across Jordan with Truecaller’s CX solution, delivering verified, trusted, and Arabic-contextualized digital learning... Read more.